Eli Igra Serfaty – Startup Investor Profile

Eli Igra Serfaty, an investment analyst and investor relations executive, is involved in the venture capital industry through iAngels, a women-led venture capital firm. Eli focuses on prospecting and assessing new companies, conducting qualitative due diligence, and collaborating with iAngels’ General Partners and Investment Committee. In 2021, iAngels deployed over $100 million in financing rounds, including investments in companies like Antidote Health, Voyage81, Better Juice, and Lynx.MD. Eli’s track record includes successful exits of portfolio companies like Arbe (NASDAQ: ARBE), Simplex, and GK8. Additionally, iAngels closed its first institutional $55.5 million fund, iAngels Ventures I, in partnership with the European Investment Fund (EIF). Eli’s investments span tech startups and scaleups, fostering growth through strategic investments and a global network of experts.

Location:

Country: Israel

Investment Regions: SEA

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Searches for ‘Eli Igra Serfaty’ on iAngels, LinkedIn and web results returned only EasyVC profile and no dated investment activity. No verifiable public record of recent investments (e.g., Antidote Health, Voyage81, Better Juice, Lynx.MD) tied to specific dates found. Unable to determine last investment date from reliable external sources, so defaulting to not-found.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.